Pediatric HLH Symptoms
In pediatric patients with hemophagocytic lymphohistiocytosis (HLH), fever is the dominant presenting symptom occurring in 96-99% of cases, accompanied by hepatosplenomegaly (77-95%), cytopenias (especially thrombocytopenia), and hyperferritinemia (97-99%), with many children presenting in clinically unstable condition requiring immediate recognition and intervention. 1, 2, 3, 4
Core Clinical Manifestations
The clinical presentation follows a recognizable pattern:
Primary Symptoms (Present in >75% of cases)
- Fever: Unremitting fever in 96.8-99.1% of patients 3, 4, 5
- Hepatomegaly: 66.3-95.6% of cases 3, 4
- Splenomegaly: 77.3-92.1% of cases 3, 4
- Lymphadenopathy: 83.6% of patients 3
Hematologic Findings
- Cytopenias: Affecting at least two cell lines, with thrombocytopenia being most prominent 1, 3
- Pancytopenia: Common, particularly in severe cases 3
Critical Laboratory Abnormalities
The characteristic laboratory profile includes:
- Hyperferritinemia: Present in 96.8-99% of cases 2, 3, 5
- Hypofibrinogenemia: 67.7% of patients 3
- Hypertriglyceridemia: 67.7% of patients 3
- Elevated soluble CD25 (sCD25): Highly prevalent 1, 3
- Decreased high-density lipoprotein cholesterol: 99.1% of cases 4
- Elevated liver enzymes: LDH, AST, ALT, HBDH commonly elevated 3
- Decreased fibrinogen, albumin, sodium: Characteristic pattern 1
- Elevated d-dimers: Part of the coagulopathy profile 1
Age Distribution and Demographics
Primary HLH predominantly occurs during childhood, with 52.7% of cases occurring in children under 3 years of age (median age 2.67 years) 3. The age range extends from birth to 18 years 2, 4.
System-Specific Involvement
Respiratory System
- Respiratory involvement: Occurs in over 50% of patients 3
- Often requires oxygen supplementation in unstable cases 5
Central Nervous System (CNS)
- CNS involvement: 22.7% of cases 3, up to 77.2% in some series 6
- Manifestations include:
- Generalized weakness
- Altered sensorium/consciousness
- Seizures
- Headaches 6
- MRI abnormalities: Patchy T2 FLAIR prolongation (85%), diffuse brain atrophy (40%), microhemorrhages (15%) 6
Multi-Organ Dysfunction
- Multiple organ dysfunction syndrome (MODS): 12.8% of cases 3
- Hepatic dysfunction with elevated enzymes
- Coagulopathy with PT (INR ≥1.5) 5
Immunologic Abnormalities
Beyond the classic HLH-2004 criteria, look for:
- Decreased NK cell proportion: 75.5% of patients 3
- Reduced CD4+/CD8+ ratio: 59.1% of cases 3
- Hemophagocytosis in bone marrow: Only 41-81.3% of patients 2, 7
Clinical Severity Indicators
61.3% of pediatric HLH patients present in clinically unstable condition requiring immediate intervention 5. Key markers of clinical instability include:
- Hypoalbuminemia: Albumin <2.5 g/dL (odds ratio 0.040 for instability) 5
- Severe hypofibrinogenemia: Significantly lower in unstable patients 5
- Hypotension: Requiring inotropic support 5
- Hypoxia: Requiring oxygen supplementation 5
- Coagulopathy: PT (INR ≥1.5) 5
- Altered consciousness or seizures 5
Critical Diagnostic Pitfall
Only 25.8% of patients meet the full HLH-2004 diagnostic criteria at initial ED presentation 5, yet many are critically ill. This creates a dangerous diagnostic gap where clinicians must maintain high suspicion based on clinical presentation and partial criteria fulfillment rather than waiting for complete criteria satisfaction.
The combination of fever with abdominal discomfort (74.2% of ED presentations) 5, hepatosplenomegaly, and cytopenias should trigger immediate HLH workup even before all diagnostic criteria are met.
Etiologic Context
Understanding the trigger helps predict presentation:
- Infection-associated HLH: 78.2% of cases, with EBV as the most common trigger (57.3%) 3
- Primary/genetic HLH: 30% when genetic testing performed 6
- Rheumatologic/malignant disease: Remaining cases 3
The mortality rate ranges from 11-29.5% 2, 4, with MODS accounting for 73.3% of fatalities 3. CNS involvement is associated with 75% of deaths 6, making neurologic surveillance critical.